Table 3.
Associations between self-reported daytime sleepiness with MRI metrics
| β | SE | p | |
|---|---|---|---|
| Total brain volume, % ICV | |||
| Continuous ESS scores | 0.328 | 0.137 | .017 |
| Excessive daytime sleepiness (ESS > 10) | 0.606 | 0.221 | .006 |
| Cortical gray matter volume, % ICV | |||
| Continuous ESS scores | 0.254 | 0.119 | .033 |
| Excessive daytime sleepiness (ESS > 10) | 0.484 | 0.193 | .013 |
| Subcortical gray matter volume, % ICV | |||
| Continuous ESS scores | −0.009 | 0.023 | .696 |
| Excessive daytime sleepiness (ESS > 10) | −0.019 | 0.037 | .613 |
| White matter hyperintensities volume, % ICV | |||
| Continuous ESS scores | 0.005 | 0.070 | .942 |
| Excessive daytime sleepiness (ESS > 10) | −0.054 | 0.110 | .626 |
| OR | 95% CI | p | |
| Covert brain infarcts, (presence/absence) | |||
| Continuous ESS scores | 0.579 | 0.358-0.937 | .026 |
| Excessive daytime sleepiness (ESS > 10) | 0.677 | 0.285-1.609 | .378 |
A natural log transformation was applied to ESS and white matter hyperintensities volume. Dichotomous ESS scores was cutoff at >10, representing excessive daytime sleepiness compared to those without. Bold values represent significant associations. MRI metrics are presented as a percentage of intracranial volume, except for covert brain infarcts. Models were adjusted for age, age squared, sex, and time between ESS and MRI assessments, APOE ε4 allele carriers, body mass index, sleeping medications, depression, and revised Framingham Stroke Risk Profile score. CI, confidence interval; ESS, Epworth Sleepiness Scale; ICV, intracranial volume; MRI, magnetic resonance imaging; OR, Odds ratio; SE, standard error.